Dr. Skrepnek's research specializations focus upon the economics of pharmaceutical mergers and acquisitions, risk and return of pharmaceutical research and development, econometrics of financial markets, and firm-level determinants of innovative activity within the drug sector. Dr. Skrepnek is also engaged in studying practice-related issues in pharmacy which include patient compliance, advanced statistical applications in pharmacoeconomics and outcomes research, knowledge-based information technology, and business management and leadership theory relating to innovation. He is a member of the CERT team that is assessing drug-drug interactions in community settings. Return to Faculty Profiles